racemetirosine has been researched along with Remission, Spontaneous in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lam, RW | 1 |
| Tam, EM | 1 |
| Grewal, A | 1 |
| Yatham, LN | 1 |
1 trial available for racemetirosine and Remission, Spontaneous
| Article | Year |
|---|---|
Effects of alpha-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remission.
Topics: Affect; alpha-Methyltyrosine; Catecholamines; Cross-Over Studies; Dopamine; Double-Blind Method; Enz | 2001 |